U.S. House Passes Health-Related Appropriations Bills for FY 2020

June, 2019 - The House passed a package of four appropriations bills, H.R. 2740, which included the Labor, Health and Human Services, and Education Appropriations bill on June 19, 2019. This package included $41.1 billion for the National Institutes of Health, a $2 billion increase from this year’s funding level. Included in NIH’s funding for FY 2020 is $500 million for the All of Us precision medicine research initiative and $195 million for the Cancer Moonshot research initiative. In addition, H.R. 2740 includes $8.3 billion for the Centers for Disease Control and Prevention ($938 million increase) and $7.6 billion for the Health Resources and Services Administration ($485 million increase).

On June 25th, the House passed another mini-bus of five appropriations bills, H.R. 3055, which provides $3.26 billion in discretionary funding for the Food and Drug Administration. This would be a $184 million increase from this year’s funding level. The total funding for FDA in FY2020, including user fees, would be $5.86 billion. This includes $75 million to accelerate medical product development as authorized in the 21st Century Cures Act.

The U.S. House of Representatives has completed 9 of the 12 appropriations bills for FY 2020. The passed appropriations bills now await action by the Senate before the end of the fiscal year on September 30, 2019.

Designed and built by Giant Rabbit.